You are here

Database of TGA laboratory testing results

11 June 2021

Important information on the Database of TGA Laboratory testing results

Safety alerts

When we identify serious safety or quality issues with therapeutic goods, information and recommendations are posted immediately on the Safety information pages of the TGA website.

This database does NOT provide timely alerts to healthcare professionals and consumers where a serious safety or quality issue has been identified.

Results of TGA Laboratory testing are released in May and November each year. There is a minimum delay of 6 months between the testing and publication of results. This delay in publication is necessary to allow the TGA to undertake any investigations and follow-up action in response to non-complying test results.

More information on laboratory testing of therapeutic goods is available at:

TGA's laboratory testing targets the most appropriate quality and/or performance aspects relevant to the product being tested. As such, a PASS result indicates a sample has met those quality/performance requirements tested by us.

The sponsors identified in these testing results were the sponsor of the product at the time the samples were received by the TGA. This may no longer be the current sponsor for the product. The current sponsor of a therapeutic good can be found by searching the Australian Register of Therapeutic Goods (ARTG).

Many unregistered therapeutic goods tested by TGA Laboratories have no packaging, labels or distinguishable product name. In this situation the goods are identified within this database using a description of the goods followed by '(unlabelled)'. E.g. Blue and White Pills (unlabelled).

More information on laboratory testing of unregistered therapeutic goods is available at: Testing of therapeutic products

About the release of this information

While reasonable care is taken to ensure that the information is an accurate record of the results and outcomes of TGA's laboratory testing, the TGA does not guarantee or warrant the accuracy, reliability, completeness or currency of the information or its usefulness in achieving any purpose.

To the fullest extent permitted by law, including but not limited to section 61A of the Therapeutic Goods Act 1989, the TGA will not be liable for any loss, damage, cost or expense incurred in or arising by reason of any person relying on this information.

Test results

Displaying 4021 - 4030 of 4081

Enter a sponsor, product name or ARTG number.

FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA / 0.5 mL PFS needle-free

Release date: Nov-2020

Testing category: Batch release evaluation

Product type: Prescription Medicines

ARTG ID: 313724

Sponsor: Seqirus Pty Ltd

Reason for testing: Batch Release

Result: PASS

Sample number: 2003001005

Batch number: 267536

Expiry date: 17-Jan-2021

FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA / 0.5 mL PFS needle-free

Release date: Nov-2020

Testing category: Batch release evaluation

Product type: Prescription Medicines

ARTG ID: 313724

Sponsor: Seqirus Pty Ltd

Reason for testing: Batch Release

Result: PASS

Sample number: 2003001006

Batch number: 267537

Expiry date: N/A

FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA / 0.5 mL PFS needle-free

Release date: Nov-2020

Testing category: Batch release evaluation

Product type: Prescription Medicines

ARTG ID: 313724

Sponsor: Seqirus Pty Ltd

Reason for testing: Batch Release

Result: PASS

Sample number: 2003000997

Batch number: 269022

Expiry date: N/A

FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA / 0.5 mL PFS needle-free

Release date: Nov-2020

Testing category: Batch release evaluation

Product type: Prescription Medicines

ARTG ID: 313724

Sponsor: Seqirus Pty Ltd

Reason for testing: Batch Release

Result: PASS

Sample number: 2003000998

Batch number: 269022

Expiry date: 16-Jan-2021

FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA / 0.5 mL PFS needle-free

Release date: Nov-2020

Testing category: Batch release evaluation

Product type: Prescription Medicines

ARTG ID: 313724

Sponsor: Seqirus Pty Ltd

Reason for testing: Batch Release

Result: PASS

Sample number: 2003000999

Batch number: 269022

Expiry date: 16-Jan-2021

FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA / 0.5 mL PFS needle-free

Release date: Nov-2020

Testing category: Batch release evaluation

Product type: Prescription Medicines

ARTG ID: 313724

Sponsor: Seqirus Pty Ltd

Reason for testing: Batch Release

Result: PASS

Sample number: 2003001000

Batch number: 269022

Expiry date: 16-Jan-2021

FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA / 0.5 mL PFS needle-free

Release date: Nov-2020

Testing category: Batch release evaluation

Product type: Prescription Medicines

ARTG ID: 313724

Sponsor: Seqirus Pty Ltd

Reason for testing: Batch Release

Result: PASS

Sample number: 2003001001

Batch number: 267536

Expiry date: N/A

FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA / 0.5 mL PFS needle-free

Release date: Nov-2020

Testing category: Batch release evaluation

Product type: Prescription Medicines

ARTG ID: 313724

Sponsor: Seqirus Pty Ltd

Reason for testing: Batch Release

Result: PASS

Sample number: 2003001071

Batch number: 268970

Expiry date: 15-Jan-2021

FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA / 0.5 mL PFS needle-free

Release date: Nov-2020

Testing category: Batch release evaluation

Product type: Prescription Medicines

ARTG ID: 313724

Sponsor: Seqirus Pty Ltd

Reason for testing: Batch Release

Result: PASS

Sample number: 2003001073

Batch number: 268970

Expiry date: 15-Jan-2021

FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA / 0.5 mL PFS needle-free

Release date: Nov-2020

Testing category: Batch release evaluation

Product type: Prescription Medicines

ARTG ID: 313724

Sponsor: Seqirus Pty Ltd

Reason for testing: Batch Release

Result: PASS

Sample number: 2003001074

Batch number: 268970

Expiry date: 15-Jan-2021

Pages